Cargando…
A vesicular stomatitis virus-based mucosal vaccine promotes dendritic cell maturation and elicits preferable immune response against coxsackievirus B3 induced viral myocarditis
Recombinant vesicular stomatitis virus (VSV) is widely used as a vaccine platform. However, the capacity of VSV-based vaccines to induce mucosal immunity has not been fully investigated. In the present study, a recombinant VSV expressing coxsackievirus B3 (CVB3) major immunogen VP1 has been generate...
Autores principales: | Wu, Fei, Fan, Xingjuan, Yue, Yan, Xiong, Sidong, Dong, Chunsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115516/ https://www.ncbi.nlm.nih.gov/pubmed/24874923 http://dx.doi.org/10.1016/j.vaccine.2014.05.052 |
Ejemplares similares
-
Appendectomy Mitigates Coxsackievirus B3−Induced Viral Myocarditis
por: Niu, Chengrui, et al.
Publicado: (2023) -
Vesicular Stomatitis Virus-Vectored Multi-Antigen Tuberculosis Vaccine Limits Bacterial Proliferation in Mice following a Single Intranasal Dose
por: Zhang, Ming, et al.
Publicado: (2017) -
Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis
por: Zhou, Lei, et al.
Publicado: (2015) -
Myocardial Mitochondrial DNA Drives Macrophage Inflammatory Response through STING Signaling in Coxsackievirus B3-Induced Viral Myocarditis
por: Qin, Andong, et al.
Publicado: (2023) -
Exosomes mediate Coxsackievirus B3 transmission and expand the viral tropism
por: Fu, Yuxuan, et al.
Publicado: (2023)